This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Showing all 7 results
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of April 2022.
Monthly #apaperaday wrap-up: March 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of March 2022.
Monthly #apaperaday wrap-up: February 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of February 2022.
Research Summary: Italian Conference on Duchenne and Becker Muscular Dystrophy
Prof. Aartsma-Rus’ personal highlights of the 2022 International Conference on Duchenne and Becker Muscular Dystrophy research updates.
Monthly #apaperaday wrap-up: January 2022
Prof. Annemieke Aartsma-Rus is taking on a challenge by reading and commenting on a paper a day. See below the overview of January 2022.
Warning on stem cell therapy in Duchenne
There are currently no approved stem cell therapies for DMD. You never pay for a clinical trial. Only trials on clinicaltrials.gov are legitimate.
Open Access: Recent studies on Duchenne muscular dystrophy
Recent studies on Duchenne muscular dystrophy (DMD) have greatly deepened our understanding of the primary and secondary pathogenetic mechanisms. Guidelines…